Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock.

Khalique, Saira C; Ferguson, Nadia

Khalique, Saira C; Ferguson, Nadia.

Affiliation

Khalique SC; From the Clinical Pharmacy, Montefiore Medical Center/The University Hospital of the Albert Einstein College of Medicine, Wakefield Division.
Ferguson N; Einstein Division, Bronx, NY.

Cardiol Rev ; 27(3): 167-169, 2019.

Article in En | MEDLINE | ID: mdl-30601161

Subject(s)

Angiotensin II/administration & dosage; Blood Pressure/drug effects; Shock, Septic/drug therapy; Vasodilation/physiology; Animals; Global Health; Humans; Infusions, Intravenous; Morbidity/trends; Shock, Septic/epidemiology; Shock, Septic/physiopathology; Survival Rate/trends; Vasoconstrictor Agents/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Septic / Vasodilation / Blood Pressure / Angiotensin II Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Cardiol Rev Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google